Clinical Role - Specialty Pharmacy
Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.
Obesity-associated cancer burden is shifting toward younger individuals, with more dramatic increases in some populations than others.
Top news of the day from across the health care landscape.
Top news of the day across the health care landscape.
Transplanting organ from patients infected with hepatitis C could greatly expand the number of kidneys available and reduce wait times.
Top news of the day across the health care landscape.
New approach involves treating patients with a high dose factor VIII concentrates along with emicizumab, a modification of the standard immune tolerance induction.
Top news of the day from across the health care landscape.
Patients with metastatic colorectal cancer harboring certain non-V600 BRAF mutations may benefit from anti-EGFR treatment.
Health-system–owned and operated specialty pharmacies have become a trend to not only capture previously unrealized profit but to also close the gap between provider, patient, and medication.
The FDA approval of pembrolizumab plus lenvatinib for this new indication is the first under a new international collaboration with Australia and Canada.
Two phase 3 studies showed that ofatumumab was superior to teriflunomide (Aubagio) in patients with relapsing forms of multiple sclerosis.
Research demonstrates a new direction in cell signaling and treatment for chronic inflammatory diseases such as psoriasis, asthma, and HIV.
+ Load More